Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review

Neuro Oncol. 2015 Jul;17(7):924-34. doi: 10.1093/neuonc/nov032. Epub 2015 Mar 25.


There is growing evidence that antitumor treatment contributes to better seizure control in low-grade glioma patients. We performed a systematic review of the current literature on seizure outcome after radiotherapy and chemotherapy and evaluated the association between seizure outcome and radiological response. Twenty-four studies were available, of which 10 described seizure outcome after radiotherapy and 14 after chemotherapy. All studies demonstrated improvements in seizure outcome after antitumor treatment. Eight studies reporting on imaging response in relation to seizure outcome showed a seizure reduction in a substantial part of patients with stable disease on MRI. Seizure reduction may therefore be the only noticeable effect of antitumor treatment. Our findings demonstrate the clinical relevance of monitoring seizure outcome after radiotherapy and chemotherapy, as well as the potential role of seizure reduction as a complementary marker of tumor response in low-grade glioma patients.

Keywords: chemotherapy; epilepsy; glioma; radiotherapy; review.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Brain Neoplasms / complications*
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / radiotherapy
  • Glioma / complications*
  • Glioma / drug therapy
  • Glioma / radiotherapy
  • Humans
  • Seizures / drug therapy
  • Seizures / etiology
  • Seizures / prevention & control*
  • Seizures / radiotherapy
  • Treatment Outcome